SBC Medical Group Holdings Inc - *W EXP 09/17/202 (SBCWW)

CUSIP: 73245B115

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class
Equity / *W EXP 09/17/202
Total 13F shares
3,580,327
Share change
+3,580,327
Total reported value
$358,000
Price per share
$0.10
Number of holders
10
Value change
+$358,000
Number of buys
10

Quarterly Holders Quick Answers

What is CUSIP 73245B115?
CUSIP 73245B115 identifies SBCWW - SBC Medical Group Holdings Inc - *W EXP 09/17/202 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SBC Medical Group Holdings Inc - *W EXP 09/17/202 (SBCWW) as of Q3 2022

As of 30 Sep 2022, SBC Medical Group Holdings Inc - *W EXP 09/17/202 (SBCWW) was held by 10 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,580,327 shares. The largest 10 holders included Polar Asset Management Partners Inc., Shaolin Capital Management LLC, ATW SPAC MANAGEMENT LLC, Hudson Bay Capital Management LP, Weiss Asset Management LP, WOLVERINE ASSET MANAGEMENT LLC, ARISTEIA CAPITAL LLC, Saba Capital Management, L.P., COWEN AND COMPANY, LLC, and CITADEL ADVISORS LLC. This page lists 10 institutional shareholders reporting positions in this security for the Q3 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.